Mechanisms of Action of Naturally Occurring Irreversible Enzyme Inhibitors

Accounts of Chemical Research

Volumn 8, Issue 8, 1975, Pages 281-288

  Rando, Robert R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000836553     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/ar50092a004     Document Type: Article

References (56)

1. M. Laskowski and R. W. Sealock, Enzymes, 3rd ed., 3, 375 (1971).
2. H. Umezawa, “Knzyme Inhibitors of Microbial Origin”. University Park Press. London, 1972, Chapter 4.
3. C. O. Chang and C. V. Lee, Arch. Int. Pharmacadyn., 144, 241 (1963).
4. D. Gottlieb and P. D. Shaw, Ed., “Antibiotics—Mechanisms of Action”, Vol. I. Springer-Verlag, New York, N.Y., 1967.
5. R. R. Rando, Science, 185, 320 (1974).
6. I. Giovanelji, L. D. Owens, and S. H. Mudd, Biochim. Biophys. Acta, 227, 671 (1971).
7. L. D. Owens, J. F. Thompson, R. G. Pitcher, and T. Williams, J. Chem. Soc., Chem. Common., 714 (1972).
8. L. D. Owens, M. Lieberman, and A. T. Kunishi, Plant Physiol., 48, 1 (1971).
9. J. P. Scannell, D. L. Preuss, T. C. Demny, L. H. Sello, T. Williams, and A. Stempel, J. Antibiot. 25, 122 (1972).
10. U. Sahn, G. Knoblock, and F. Wagner, J. Antibiot., 26, 389 (1973).
11. D. L. Preuss, J. P. Scannell, M. Kellett, H. A. Ax, J. Janecek, T. H. Williams, A. Stempel, and J. Berger, J. Antibiot., 27, 229 (1974).
12. R. R. Rando, Nature (London), 250, 586 (1974).
13. R. R. Rando, Biochemistry, 13, 3859 (1974).
14. G. Dardenne, J. Casimir, M. Marlier, and P. O. Larsen, Phytochemistry, 13, 1897 (1974).
15. H. Gershon, J. S. Meek, and K. Kittmer, J. Am. Chem. Soc., 71, 3573 (1949).
16. J. P. Scanned, D. L. Preuss, T. C. Demny, F. Weiss, T. Williams, and A. Stempel, J. Antibiot., 24, 239 (1971).
17. R. H. Abeles and C. T. Walsh, J. Am. Chem. Soc., 95, 6124 (1973).
18. F. C. Meuhaus in “Antibiotics—Mechanisms of Action”, Vol. I. Springer-Verlag, New York, N.Y., 1967, pp 64 69.
19. U. Roze and J. L. Strominger, Fed. Proc. Abstr., 22, 423 (1963).
20. F. C. Meuhaus, Antinucrob. Agents Annu., 304 (1968).
21. M. Ya Karplisky, R. M. Khomutov, E. S. Severin, and Yu N. Breusiv, in “Chemical and Biological Aspects of Pyridoxal Catalysis”, E. E. Snell et al., Ed., Wiley, New York, N.Y., 1963, pp 323.
22. R. M. Khomutov, E. S. Severin, G. K. Kovaleva, M. M. Gulyaev, M. U. Gnuchev, and L. P. Sasichenko, in “Pyridoxal Catalysis: Enzymes and Model Systems”, E. E. Snell et al., Ed., Wiley, New York, N.Y. 1968, p 639.
23. L. A. Emrhurt, S. H. Lipton, and F. M. Strong, Biochemistry, 2, 300 (1963).
24. W. A. Wood and J. C. Gunsalus, J. Biol. Chem., 181, 171 (1949).
25. A. T. Philips, Biochim, Biophys. Acta, 151, 171 (1968).
26. Y. Morino and M. Okamoto, Biochem. Biophys. Res. Commun., 50, 1061 (1973).
27. L. J. Fowler and R. A. John, Biochem. J., 130, 569 (1972).
28. L. Fowden, Annu. Rev. Biochem., 33, 173 (1964).
29. J. Y. Lin, Y. M. Shik, and K. H. Ling, J. Formosan Med. Assoc., 61, 997 (1962).
30. J. Y. Lin, T. A. Ling, and T. C. Tung, J. Formosan Med. Assoc., 64, 265 (1965).
31. R. B. Livingston, J. M. Verditti, D. A. Cooney, and S. K. Carter, in Adv. Pharm. Chemother., 8, 57 (1970).
32. G. E. Means and R. E. Feeney, “Chemical Modification of Proteins”, Holden-Day, Inc., San Francisco, Calif., 1971.
33. T. C. French, I. B. Dawid, R. A. Day and J. M. Buchanan, J. Biol. Chem., 238, 2171 (1963).
34. I. B. Dawid, T. C. French, and J. M. Buchanan, J. Biol. Chem., 238, 2186 (1963).
35. B. F. Erlanger, S. M. Vralsanos, M. Wassermann, and A.G. Cooper, Biochem. Biophys. Res. Commun., 23, 243 (1966).
36. T. G. Rajngopalan, W. H. Stein, and S. Moose, J. Biol. Chem., 241, 4295 (1966).
37. E. F. Gall, E. Curdiute, P. H. Reynolds, M. H. Richmond, and M. J. Waring, “The Molecular Basis of Antibiotic Action”. Wiley, New York, N.Y., 1972, Chapter 3.
38. O. M. Blumberg and J. L. Strominger, Bact. Rev., 38, 291 (1974).
39. D. J. Tipper and J. L. Strominger, Proc. Nat. Acad. Sci. U.S.A., 54, 4133 (1965).
40. B. R. Baker, “Design of Active-Site Directed Irreversible Enzyme Inhibitors”, Wiley, New York, N.Y., 1967.
41. R. M. Sweet in “Cephalosporins and Penicillins”, E. H. Flynn, Ed., Academic Press, New York, N.Y., 1972, Chapter 7.
42. M. Gorman and C. W. Ryan “Cephalosporins and Penicillins”, E. H. Flynn, Ed., Academic Press, New York, N.Y., 1972, Chapter 12.
43. K. Izaki and J. L. Strominger, J. Biol. Chem., 243, 3193 (1968).
44. M. Legh-Boniile, M. Makel, J. M. Frire, K. Johnson, J. M. Ghuysen, M. Mieto, and H. R. Perkins, Biochemistry, 11, 1290 (1972).
45. J. M. Umbreit and J. L. Strominger, J. Biol. Chem., 248, 6767 (1973).
46. H. C. Froede and J. B. Wilson, Enzymes, 3rd Ed., 5, 87 (1971).
47. G. B. Koelle in “The Pharmacological Basis of Therapeutics”, L. S. Goodman and A. Gilman, Ed., 4th ed., Macmillan Co., New York, N.Y., 1970, Chapter 22.
48. S. J. Singer, Adv. Protein Chem., 22, 1 (1967).
49. D. Schroeder, A. J. Allison, and J. M. Buchanan, J. Biol. Chem., 244, 5856 (1969).
50. J. M. Buchanan, Adv. Enzymol., 39, 91 (1973).
51. R. A. Ronzio and A. Meister, Proc. Nat. Acad. Sci. US.A., 59, 164 (1968).
52. B. W. Christensen and A. Kjoer, Chem. Commun., 169 (1969).
53. R. Wolfenden, Acc. Chem. Res., 5, 10 (1972).
54. G. E. Lienhard, Science, 180, 149 (1973).
55. D. L. Preuse, J. P. Scanned, H. A. Ax, M. Kellett, F. Weiss, T. C. Demny, and A. Stempel, J. Antibiot., 26, 261 (1973).
56. W. W. Stewart, Nature (London), 229, 174 (1971).